---
title: 'Non-steroidal anti-inflammatory medication use and endometrial cancer survival:
  A population-based Norwegian cohort study'
date: '2025-02-24'
linkTitle: https://pubmed.ncbi.nlm.nih.gov/39992017/?utm_source=curl&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&fc=20220326224207&ff=20250224170911&v=2.18.0.post9+e462414
source: heidelberg[Affiliation]
description: While nonsteroidal anti-inflammatory drugs (NSAIDs) have been shown to
  improve survival in certain cancers, data in patients with endometrial cancer (EC)
  is conflicting. This study investigated use of aspirin and nonaspirin NSAIDs (NA-NSAIDs)
  and EC-specific-and all-cause death. This nationwide cohort study linked data from
  the Cancer Registry of Norway with The Norwegian Prescription database. Patients
  diagnosed with EC from 2004 to 2018 were included. Post-diagnosis exposure to aspirin
  ...
disable_comments: true
---
While nonsteroidal anti-inflammatory drugs (NSAIDs) have been shown to improve survival in certain cancers, data in patients with endometrial cancer (EC) is conflicting. This study investigated use of aspirin and nonaspirin NSAIDs (NA-NSAIDs) and EC-specific-and all-cause death. This nationwide cohort study linked data from the Cancer Registry of Norway with The Norwegian Prescription database. Patients diagnosed with EC from 2004 to 2018 were included. Post-diagnosis exposure to aspirin ...